Ondansetron HCl
CAS No. 99614-01-4
Ondansetron HCl( GR 38032 (hydrochloride) | SN 307 (hydrochloride) )
Catalog No. M19305 CAS No. 99614-01-4
Ondansetron is a serotonin 5-HT3 receptor antagonist, used to prevent nausea and vomiting caused by cancer chemotherapy, and radiation therapy.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 37 | In Stock |
|
| 25MG | 35 | In Stock |
|
| 50MG | 49 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameOndansetron HCl
-
NoteResearch use only, not for human use.
-
Brief DescriptionOndansetron is a serotonin 5-HT3 receptor antagonist, used to prevent nausea and vomiting caused by cancer chemotherapy, and radiation therapy.
-
DescriptionOndansetron is a serotonin 5-HT3 receptor antagonist, used to prevent nausea and vomiting caused by cancer chemotherapy, and radiation therapy.
-
In Vitro——
-
In Vivo——
-
SynonymsGR 38032 (hydrochloride) | SN 307 (hydrochloride)
-
PathwayOthers
-
TargetOther Targets
-
Recptor5-HT3
-
Research AreaCancer|Neurological Disease
-
Indication——
Chemical Information
-
CAS Number99614-01-4
-
Formula Weight329.82
-
Molecular FormulaC18H19N3O·HCl
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCl.CN1C2=CC=CC=C2C2=C1CCC(CN1C=CN=C1C)C2=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
7-hydroxycoumarinyl-...
7-hydroxycoumarinyl-γ-Linolenate is a γ-linolenic acid ester of 7-hydroxycoumarin (umbelliferone) that behaves as a substrate for cPLA2. Hydrolysis of 7-hydroxycoumarinyl-γ-linolenate by phospholipase results in the release of the fluorescent compound 7-hydroxycoumarin which can be monitored spectrophotometrically (excitation at 335 nm, emission at 450 nm).
-
Remimazolam
Remimazolam is a benzodiazepine derivative drug as an alternative to the short-acting imidazobenzodiazepine midazolam, for use in induction of anaesthesia and conscious sedation for minor invasive procedures.?Remimazolam was found to be both faster acting and shorter lasting than midazolam, and human clinical trials showed a faster recovery time and predictable, consistent pharmacokinetics, suggesting some advantages over existing drugs for these applications.?
-
Merepoxine N-oxide
Merepoxine N-oxide
Cart
sales@molnova.com